Live attenuated vaccine · VDDBV0846
Note: 5 additional source trials listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.
| NCT ID | Phase | Disease / Condition |
|---|---|---|
| NCT00130793 | Phase 3 | Hepatitis A; Measles; Mumps; Rubella; Chickenpox |
| NCT03192319 | — | Varicella |
| NCT01213810 | Phase 2 | Psoriasis |
| NCT01573182 | Phase 2 | Herpes Zoster; Inflammatory Disease; Rheumatoid Arthritis |
| NCT01391546 | Phase 3 | Immunosenescence; Shingles |
| NCT03016884 | Approved | Rubella; Mumps; Measles; Measles-Mumps-Rubella Vaccine |
| NCT04169009 | Phase 1 | Tetanus; Acellular Pertussis; Diphtheria |
| NCT00681031 | Approved | Varicella |
| NCT01911065 | Approved | Shingles; Herpes Zoster; Vaccine-Preventable Diseases |
| NCT00231816 | Phase 3 | Herpes Zoster |
| NCT01385566 | Phase 1 | Herpes Zoster |
| NCT02519855 | Phase 3 | Herpes Zoster |
| NCT00322231 | Phase 3 | Herpes Zoster |
| NCT00546819 | Phase 2 | Herpes Zoster |
| NCT00550745 | Approved | Herpes Zoster |
| NCT02958345 | Approved | Herpes Zoster |
| NCT00851786 | Phase 2 | Herpes Zoster |
| NCT00535730 | Phase 3 | Herpes Zoster |
| NCT01527370 | Phase 3 | Herpes Zoster |
| NCT01556451 | Approved | Herpes Zoster |
| NCT01505647 | Phase 3 | Herpes Zoster |
| NCT01245751 | Phase 3 | Herpes Zoster |
| NCT00940940 | Approved | Herpes Zoster |
| NCT00005009 | Phase 1 | Herpes Zoster |
| NCT00561080 | Phase 3 | Herpes Zoster; Fibrosis |
| NCT01506661 | Phase 1 | Herpes Zoster; HIV Infections |
| NCT02704572 | — | Herpes Zoster; Pneumococcal Infection |
| NCT01331161 | — | Herpes Zoster; Shingles |
| NCT02444936 | Approved | Kidney Transplant Recipients |
| NCT02624375 | Approved | Herpes-Zoster |
| NCT00109122 | Phase 2 | Rheumatoid Arthritis; Varicella Zoster |
| NCT00534248 | Phase 3 | Shingles |
| NCT02114333 | Phase 1 | Shingles |
| NCT01474720 | Phase 1 | Shingles |
| NCT03239873 | Phase 3 | Shingles |
| NCT03843632 | Phase 3 | Shingles |
| NCT02062502 | Phase 3 | Shingles |
| NCT01626794 | Phase 3 | Systemic Lupus Erythematosus |
| NCT00444860 | Phase 3 | Varicella |
| NCT02329457 | Phase 3 | Varicella |
| NCT03121638 | Phase 1 | Varicella |
| NCT00432731 | Approved | Varicella |
| NCT01137669 | Phase 1 | Varicella Virus Infection |
| NCT02408159 | Approved | Varicella Zoster Infection |
| NCT03604406 | Phase 2 | Varicella Zoster; Infection |
| NCT01262300 | Phase 1 | Varicella; Measles; Mumps; Rubella |